During the past decade, Comitato Etico Fondazione Irccs Istituto Nazionale Dei Tumori Milano conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Comitato Etico Fondazione Irccs Istituto Nazionale Dei Tumori Milano" #1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Comitato Etico Fondazione Irccs Istituto Nazionale Dei Tumori Milano" are "B-Cell Malignancies" (1 trials), "Endometrial Cancer" (1 trials), "Follicular Lymphoma" (1 trials), "Marginal Zone Lymphoma" (1 trials) and "Squamous Cell Carcinoma of the Anal Canal" (1 trials). Many other conditions were trialed in "Comitato Etico Fondazione Irccs Istituto Nazionale Dei Tumori Milano" in a lesser frequency.

Most popular intervention types in "Comitato Etico Fondazione Irccs Istituto Nazionale Dei Tumori Milano" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "retifanlimab" (2 trials), "INCAGN02385" (1 trials), "INCAGN02390" (1 trials), "Parsaclisib" (1 trials) and "carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Comitato Etico Fondazione Irccs Istituto Nazionale Dei Tumori Milano" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Comitato Etico Fondazione Irccs Istituto Nazionale Dei Tumori Milano". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Comitato Etico Fondazione Irccs Istituto Nazionale Dei Tumori Milano, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Comitato Etico Fondazione Irccs Istituto Nazionale Dei Tumori Milano, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".